Pediatric Influenza-Associated Encephalopathy Highlights of 2024–2025 Season

The 2024–2025 flu season in the U.S. saw a rise in pediatric influenza-associated encephalopathy cases, including severe forms like ANE, with high hospitalization and mortality rates among children. Vaccination coverage remains crucial to prevent these severe outcomes.
The 2024–2025 influenza season in the United States saw significant cases of pediatric influenza-associated encephalopathy (IAE), including the severe form known as acute necrotizing encephalopathy (ANE). According to a report published in the Morbidity and Mortality Weekly Report by the CDC, 109 children developed IAE during this period. The season was notably severe, with a record number of pediatric influenza-related deaths prompting increased surveillance and reporting.
In total, 192 reports of suspected IAE were submitted to the CDC, with 109 cases confirmed as IAE—comprising 34% with ANE and 66% with other forms of IAE. The median age of affected children was five years, and over half had no pre-existing health conditions. Tragically, among children diagnosed with IAE, 74% required intensive care, and 19% succumbed to the illness. Specifically, 41% of those with ANE died.
Vaccination data revealed that only 16% of eligible children had received the 2024–2025 flu vaccine, highlighting potential gaps in immunization coverage. Experts emphasize the importance of healthcare providers considering IAE in children presenting with febrile illnesses and neurological symptoms, to facilitate early diagnosis and supportive care.
The report underscores the need for increased awareness and vaccination efforts to mitigate severe influenza complications in children. For more detailed information, visit the CDC's Morbidity and Mortality Weekly Report.
Source: https://medicalxpress.com/news/2025-10-highlights-pediatric-influenza-encephalopathy-season.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Research Shows Surfactant Treatment Offers No Additional Benefit for Critically Ill Infants with Severe Bronchiolitis
A large UK trial reveals that surfactant therapy offers no added benefit for infants with severe bronchiolitis, emphasizing the importance of supportive care and preventive measures like RSV vaccination.
Innovative Approach Reduces Stroke Risk in Heart Failure Patients with LVADs
New research utilizing blood flow modeling offers promising strategies to reduce stroke risk in patients with LVADs, improving the safety and personalization of heart failure treatments.
Breakthrough in Muscle Regeneration: Identifying the 'Control Center' to Improve Elderly Muscle Healing
A groundbreaking study reveals a cellular 'control center' in muscle tissue that could revolutionize treatments for age-related muscle loss and improve healing in the elderly through new cellular communication pathways.
Expert-Fitted Hearing Aids Show Greater Effectiveness Than Over-the-Counter Options
A recent study reveals that hearing aids fitted by audiologists provide better outcomes than over-the-counter devices, emphasizing the importance of professional fitting for optimal hearing health.



